BREAKING! Texas MD Anderson Study Finds That COVID-19 Accelerates Brain Tumor Progression And Possibly Causes New Onset Glioblastomas!

COVID-19 News: The intersection of COVID-19 and cancer has been an area of intense scrutiny since the onset of the pandemic. Recently, a groundbreaking study conducted at The University of Texas MD Anderson Cancer Center in the USA has shed light on a concerning aspect of this intersection. The study reveals compelling evidence of a heightened risk and aggressive progression of glioblastoma following COVID-19 infection. This COVID-19 News report delves into the background, methodology, results, and implications of this pivotal research.


COVID-19 Accelerates Brain Tumor Progression And Possibly Causes New Onset Glioblastomas

Thailand Medical News had previously reported that the risk of developing glioblastoma was increased in hospitalized COVID-19 patients with disease severity.

https://www.thailandmedical.news/news/breaking-covid-19-news-study-finds-that-covid-19-hospitalization-linked-to-elevated-glioblastoma-risk-a-type-of-aggressive-brain-cancer
 
However newer data shows that even asymptomatic, mild or moderate COVID-19 infected individuals are at risk of new onset glioblastoma and those already with glioblastoma are at risk of accelerated progression of the tumor due to the SARS-CoV-2 virus!
https://www.thailandmedical.news/news/sars-cov-2-and-cancer-increased-neuropilin-1-expression-as-a-result-of-covid-19-can-lead-to-progression-of-primary-brain-tumors-besides-neurological-i
 
It is also believed that the COVID-19 mRNA jabs can also play a role in the development and progression of glioblastoma!
https://www.thailandmedical.news/news/urgent-validation-needed-on-study-findings-showing-that-covid-19-mrna-jabs-altered-the-biochemical-composition-of-glial-and-glioma-brain-cells
 
It should also be noted that studies have already validated that viral infections do increase the risk of glioblastomas!
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-023-03142-9
 
Background: Unraveling the Nexus of COVID-19 and Glioblastoma
Glioblastoma, a highly malignant brain tumor, poses significant challenges in terms of treatment and prognosis. Amid the COVID-19 pandemic, researchers have been intrigued by the potential interactions between SARS-CoV-2, the virus causing COVID-19, and cancer progression, particularly in the context of central nervous system tumors like glioblastoma.
 
Initial observations hinted at neurological implications of COVID-19, with a notable percentage of patients displaying neurologic symptoms. Moreover, studies exploring the molecular mechanisms of SARS-CoV-2's interaction with neural tissues revealed intriguing pathways that could influence tumor biology. For instance, the virus's ability to induce neurotoxicity through various signaling pathways such as MAPK, NF-κB, and p53 activation raised questions about its potential impact on glioblastoma progression.
 
Furthermore, the differential expression of coronavirus receptors in glioblastoma tissues compared to normal tissues, along with their association with immune cell infiltration and prognosis, added complexity to this interplay. Insights from COVID-19 research also highlighted enduring dysregulation of inflammation and immune responses, factors intricately linked to tumor microenvironments and immunophenotypes.
 
Methodology: A Retrospective Case-Control Study
The MD Anderson study employed a retrospective case-control design to investigate the progression of glioblastoma in the context of COVID-19 infection. The researchers identified two cohorts: glioblastoma patients with documented COVID-19 infection (cases) and glioblastoma patients without COVID-19 (controls), matched for age, sex, and other relevant variables.
 
Key aspects of the methodology included:
 
-Patient Selection: Inclusion of glioblastoma patients with positive COVID-19 testing and age-sex matched controls with negative COVID-19 testing during their disease course.
 
-Data Analysis: Comparison of demographic, clinical, and molecular profile data between cases and controls.
 
-Outcome Measures: Assessment of tumor progression, hyperprogression rates, time to progression, overall survival, and new glioblastoma diagnoses post-COVID-19 infection.
 
Results: Accelerated Tumor Progression and Clinical Implications
The findings from the MD Anderson study unveiled significant differences in tumor progression dynamics and patient outcomes between cases and controls:
 
-Tumor Progression Rates: Cases exhibited rapid tumor progression post-COVID-19 infection, with a higher prevalence of multifocality, leptomeningeal disease, and hyperprogression compared to controls.
 
-Time to Progression: The median time to progression was markedly shorter in cases than controls, highlighting the accelerated disease course following COVID-19.
 
-Overall Survival: Patients with glioblastoma and COVID-19 experienced reduced overall survival compared to those without COVID-19, underscoring the impact of viral infection on long-term outcomes.
 
-New Diagnoses: Interestingly, a subset of patients developed new glioblastoma diagnoses shortly after COVID-19 infection, suggesting a potential link between viral exposure and tumor initiation or exacerbation.
 
Discussion: Unraveling Mechanisms and Future Directions
The study's findings raise intriguing questions about the underlying mechanisms driving accelerated tumor progression in the context of COVID-19. Several hypotheses and avenues for future research emerge from these results:
 
-Immune Dysregulation: The enduring dysregulation of immune responses post-COVID-19 may create a permissive environment for glioblastoma growth and aggressive behavior. Understanding the specific immune pathways involved could offer insights into targeted interventions.
 
-Direct Viral Effects: SARS-CoV-2's neurotropism and potential direct effects on neural tissues, including activation of pro-inflammatory pathways and disruption of cellular signaling, may contribute to tumor permissiveness and inflammation.
 
-Impact of Vaccination: The role of COVID-19 vaccination in tumor biology and progression warrants further investigation, especially considering potential interactions between vaccine-induced immune responses and tumor microenvironments.
 
Conclusion: Implications for Clinical Practice and Research
The MD Anderson study's findings have significant implications for clinical practice and future research directions in neuro-oncology and COVID-19:
 
-Clinical Vigilance: Glioblastoma patients with a history of COVID-19 should receive vigilant monitoring for accelerated disease progression and early intervention strategies.
 
-Immunotherapeutic Strategies: Exploring the interplay between COVID-19-induced immune changes and glioblastoma could inform novel immunotherapeutic approaches tailored to individual patient profiles.
 
-Long-Term Follow-Up: Longitudinal studies tracking the long-term effects of COVID-19 on glioblastoma outcomes are essential for understanding the evolving landscape of this complex interaction.
 
In essence, the MD Anderson study represents a crucial step forward in unraveling the intricate relationship between COVID-19 and glioblastoma progression, paving the way for targeted interventions and improved patient care in this challenging clinical scenario.
 
The study findings were published in the peer reviewed journal: Neuro-Oncology Practice (Oxford Journals).
https://academic.oup.com/nop/advance-article/doi/10.1093/nop/npae029/7642126
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/covid-19-news-scientists-warn-that-existing-mrna-covid-19-prophylactics-create-environment-for-neoplastic-transformation-leading-to-various-cancers
 
https://www.thailandmedical.news/news/breaking-covid-19-news-doctors-in-thailand-warn-that-covid-19-vaccines-could-possibly-lead-to-tumor-expansion-in-certain-cancers
 
https://www.thailandmedical.news/news/texas-md-anderson-cancer-center-warns-that-covid-19-mrna-vaccines-elevate-pd-l1-levels-disrupting-lung-cancer-treatments-progressing-other-cancers
 
https://www.thailandmedical.news/news/south-korean-preprint-study-five-months-ago-warns-that-covid-19-mrna-vaccines-can-cause-a-variety-of-blood-disorders-including-aplastic-anemia
 
https://www.thailandmedical.news/news/breaking-sars-cov-2-causes-aggressive-breast-cancer-progression-and-manipulates-tissue-stem-cells-in-the-tumor-microenvironment
 
https://www.thailandmedical.news/news/breaking-news-gene-study-reveals-how-covid-19-mrna-vaccine-leads-to-high-risk-of-iga-nephropathy-eventual-kidney-failure-and-possible-cancers
 
https://www.thailandmedical.news/news/breaking-hla-g-protein-which-is-typically-upregulated-in-cancers-found-to-be-also-upregulated-in-covid-19-infections
 
https://www.thailandmedical.news/news/covid-19-can-enhance-the-invasiveness-and-progression-of-oral-squamous-cell-cancer
 
https://www.thailandmedical.news/news/various-peer-reviewed-published-studies-and-case-reports-show-that-mrna-covid-19-vaccines-can-cause-lymphoma

https://www.thailandmedical.news/news/breaking-news-chinese-researchers-discover-circrnas-encoded-by-sars-cov-2-virus-that-can-cause-cancer-millions-expected-to-get-cancer-eventually
 
https://www.thailandmedical.news/news/must-read-covid-19-questions-can-the-sars-cov-2-coronavirus-ultimately-also-cause-cancer
 
https://www.thailandmedical.news/news/covid-19-and-cancer-study-shows-that-sars-cov-2-and-usage-of-anti-covid-19-drugs-can-reactivate-oncogenic-viruses-and-increase-risk-of-cancer
 
https://www.thailandmedical.news/news/breaking-new-international-study-warns-that-sars-cov-2-infections-will-lead-to-cancers-especially-colorectal-cancers-due-to-disruption-in-autophagy
 
https://www.thailandmedical.news/news/breaking-sars-cov-2-infection-induces-increase-of-gp73-that-causes-dysglycaemia-increased-gp73-could-also-imply-future-liver-disease-and-liver-cancer
 
https://www.thailandmedical.news/news/breaking-study-finds-that-cancer-causing-genes-are-upregulated-in-sars-cov-2-infected-individuals
 
https://www.thailandmedical.news/news/post-covid-19-individuals-advised-to-take-probiotics-as-study-shows-sars-cov-2-induced-gut-microbiome-dysbiosis-increases-risk-for-colorectal-cancer
 
https://www.thailandmedical.news/news/breaking-study-discovers-sars-cov-2-could-be-carcinogenic-as-it-causes-mutagenesis,-telomere-dysregulation-and-impairs-dna-mismatch-repair
 
https://www.thailandmedical.news/news/breaking-sars-cov-2-activates-epidermal-growth-factor-receptor-mediated-signaling,-inducing-survivin-expression-which-assists-in-cancer-progression
 
https://www.thailandmedical.news/news/great-news-study-shows-that-sars-cov-2-protein-nsp13-is-able-to-cause-dna-damage-and-dysregulate-tumor-suppressor-gene-p53,-increasing-cancer-risk

https://www.thailandmedical.news/news/breaking-study-finds-that-upregulated-interleukin-6-drives-development-of-rare-liver-cancers-covid-19-infections-causes-elevated-il-6-levels-in-many
 
https://www.thailandmedical.news/news/spanish-study-discovers-that-sars-cov-2-infections-leads-to-downregulation-of-p53-a-critical-cancer-protective-gene
 
https://www.thailandmedical.news/news/breaking-researchers-from-brazil-warn-sars-cov-2-induced-immunological-dysregulation-can-increase-the-risk-of-skin-and-blood-cancer-relapses
 
https://www.thailandmedical.news/news/breaking-covid-19-news-sars-cov-2-infections-lead-to-cellular-m6a-rna-methylation-loss-in-host-cells-possible-implications-for-cancer-and-other-issues
 
https://www.thailandmedical.news/news/covid-19-news-will-sars-cov-2-infections-ultimately-lead-to-an-increased-incidence-of-head-and-neck-cancers
 
https://www.thailandmedical.news/news/breaking-covid-19-news-sars-cov-2-infections-lead-to-increased-risk-of-breast-cancer,-recurrence-of-breast-cancer-and-also-breast-cancer-metastasis
 
https://www.thailandmedical.news/news/understanding-the-link-between-covid-19-and-cancer-the-role-of-the-slc6a20-gene
 
https://www.thailandmedical.news/news/2021-peer-reviewed-study-warning-that-covid-19-can-lead-to-pancreatic-adenocarcinoma-seems-to-be-holding-true-as-pancreatic-cancer-cases-rise
 
https://www.thailandmedical.news/news/breaking-news-french-physicians-uncover-malignant-pseudothyroiditis,-a-new-type-of-thyroid-cancer-in-a-post-covid-individual
 
https://www.thailandmedical.news/news/breaking-news-researchers-find-that-sars-cov-2-contributes-to-oral-cancer-progression,-treatment-resistance-and-tumor-recurrence
 
https://www.thailandmedical.news/news/breaking-news-doctors-warn-covid-19-induced-t-cell-exhaustion-linked-to-oncovirus-reactivation-and-development-of-various-cancers